TrialEuropean urology2026
Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial.
Arvin K George et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papertrialcites it